Alphatec Holdings, Inc. (ATEC) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Alphatec Holdings, Inc. (ATEC) closed at USD 10.44 on 2026-10-14, a change of -37.3 % over the past year, with a market capitalization of USD 1.68B.

Alphatec Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Alphatec Holdings, Inc. key figures

Previous close

USD 10.44 (2026-10-14)

1-year change

-37.3 %

Market cap

USD 1.68B

Enterprise value

USD 2.2B

P/E ratio (trailing)

-14.97

P/E ratio (forward)

18.21

EPS (trailing)

-0.73

EPS (forward)

0.60

PEG ratio

0.48

Price to book

-138.35

Revenue growth

15.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.13

Employees

913

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Alphatec Holdings, Inc. and compare it with other stocks.